Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765

December 5, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. and SUNNYVALE, Calif., Dec. 5, 2010 /- Pharmacyclics, Inc. (Nasdaq: PCYC ) today announced data from three Chronic Lymphocytic Leukemia (CLL) presentations at the American Society of Hematology (ASH) Annual Meeting describing the Btk-selective inhibitor PCI-32765.  Two...

TOPICS:

Northern wildfires threaten runaway climate change, study reveals

December 5, 2010 9:33 am | by EurekAlert | News | Comments

(University of Guelph) This study reveals that fires in the Alaskan interior have become more severe in the last decade, resulting in more carbon being released than is being stored. About half the world's soil carbon is locked in northern permafrost and peatland soils. The increased...

TOPICS:

Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting

December 4, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Dec. 4, 2010 /- Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK...

TOPICS:
Advertisement

UIC researcher unveils new approach to blocking malaria transmission

December 4, 2010 4:36 am | by EurekAlert | News | Comments

(University of Illinois at Chicago) University of Illinois at Chicago researcher Dr. John Quigley unveils a new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla.

TOPICS:

Infineon and Goldwind sign a license agreement on IGBT stack technology to serve wind power market

December 3, 2010 10:38 pm | by I-Micronews | News | Comments

Infineon Technologies AG and Xinjiang Goldwind Science and Technology Co., Ltd., the Chinese leader in R&D and manufacturing of wind power equipments, today signed a license agreement for core components needed in manufacturing of wind turbines.

Crystal IS receives $5 million DARPA award

December 3, 2010 10:37 pm | by I-Micronews | News | Comments

Crystal IS Inc., of Gree Island, New York USA, a developer of ultraviolet LEDs (UVC LEDs), today announced it has been awarded $5M by the Defense Advanced Research Projects Agency (DARPA).

Momenta hits Teva with IP lawsuit

December 3, 2010 7:36 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Momenta Pharmaceuticals Inc. has filed a lawsuit against Teva Pharmaceutical Industries Ltd. alleging two cases of patent infringement, according to a Momenta press release. The suit was filed in the U.S. District Court for the District of Massachusetts.

Direct writing of sub-5 nm metallic nanostructures

December 3, 2010 7:36 pm | by I-Micronews | News | Comments

A group of Beckman Institute researchers have discovered a practical method for direct writing of metal lines less than five nanometers (5 nm) wide, a big step in creating contacts to and interconnects between nanoscale device structures like carbon nanotubes and graphene that have...

Advertisement

GE Capital to invest $10 million dollars in Nano fiber technology company Finetex EnE, Inc.

December 3, 2010 7:36 pm | by I-Micronews | News | Comments

Finetex EnE, Inc., a Korea based manufacturer of electrospun nano fibers, disclosed November 25, 2010 that its Board of Directors has approved the terms of a private issue of Convertible Bonds to GE Capital valued at $10 million.

Nanostart-Holding Nanosys: Distribution Agreement with Multi-Billion Dollar Cooperation Sigma-Aldrich

December 3, 2010 7:36 pm | by I-Micronews | News | Comments

(BUSINESS WIRE)--Nanostart (OTCQX:NASRY)-holding Nanosys has entered into a distribution agreement with multi-billion dollar concern Sigma-Aldrich (Nasdaq: SIAL).

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza

December 3, 2010 7:35 pm | by Bio-Medicine.Org | News | Comments

SEATTLE, Dec. 4, 2010 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority (BARDA). IDRI's work will focus on development of adjuvant formulations with options...

TOPICS:

Citing New Technologies, FDA Updates C. Difficile Guidance(3)

December 3, 2010 2:42 pm | by U.S. Food & Drug Administration | News | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Anchor Products Gets a Warning for Complaint Handling, MDRs

December 3, 2010 2:34 pm | by U.S. Food & Drug Administration | News | Comments

Anchor Products has received a warning letter citing it for a number of issues, including handling of complaints and medical device reports (MDRs).

TOPICS:

Citing New Technologies, FDA Updates C. Difficile Guidance(2)

December 3, 2010 2:33 pm | News | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Citing New Technologies, FDA Updates C. Difficile Guidance

December 3, 2010 2:32 pm | News | Comments

Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading